` Comparison: REGN vs LLY - Alpha Spread

REGN
vs
LLY

Over the past 12 months, REGN has underperformed LLY, delivering a return of +9% compared to the LLY's +15% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
REGN
LLY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

REGN Intrinsic Value
HIDDEN
Show
LLY Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
778.555 USD
Eli Lilly and Co
NYSE:LLY
1 014.26 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
REGN, LLY

REGN
LLY
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Regeneron Pharmaceuticals Inc
Revenue
Eli Lilly and Co
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
REGN, LLY

REGN
LLY
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Eli Lilly and Co
NYSE:LLY
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

REGN
86.6%
LLY
83%

Operating Margin

REGN
27%
LLY
45.6%

Net Margin

REGN
31.4%
LLY
31.7%

FCF Margin

REGN
26.3%
LLY
9.9%

ROE

REGN
14.9%
LLY
108.7%

ROA

REGN
11.5%
LLY
21.3%

ROIC

REGN
18%
LLY
27.6%

ROCE

REGN
11.1%
LLY
47.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
REGN, LLY

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
REGN, LLY

Performance Gap Between REGN and LLY
HIDDEN
Show

Performance By Year
REGN, LLY

Loading
REGN
LLY
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare REGN to other stocks
MRK
Merck & Co Inc
AMGN
Amgen Inc
VRTX
Vertex Pharmaceuticals I...
BMY
Bristol-Myers Squibb Co
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account